Sex-dependent anti-stress effect of an α5 subunit containing GABAA receptor positive allosteric modulator

Frontiers in Pharmacology

Volumn 7, Issue NOV, 2016, Pages

  Piantadosi, Sean C ^a,b   French, Beverly J ^b   Poe, Michael M ^c   Timic, Tamara ^d   Markovic, Bojan D ^d   Pabba, Mohan ^e   Seney, Marianne L ^b   Oh, Hyunjung ^a,b,e   Orser, Beverley A ^f   Savic, Miroslav M ^d   Cook, James M ^c   Sibille, Etienne ^a,b,e,g  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alph 5; Depression; GABA; Gabr 5; Interneurons; PAM

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA5; ALPHA5 POSITIVE ALLOSTERIC MODULATOR; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTI STRESS EFFECT; ARTICLE; BEHAVIOR; CHRONIC DRUG ADMINISTRATION; CHRONIC STRESS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG SCREENING; EMOTIONALITY; FEMALE; GABRA5 GENE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRELIMBIC CORTEX; SEX DIFFERENCE;

EID: 85003691586     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00446     Document Type: Article

References (75)

1. A receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex. Cereb. Cortex 18, 1260-1271. doi: 10.1093/cercor/bhm160
2. Anacker, C., Scholz, J., O'Donnell, K. J., Allemang-Grand, R., Diorio, J., Bagot, R. C., et al. (2016). Neuroanatomic differences associated with stress susceptibility and resilience. Biol. Psychiatry 79, 840-849. doi: 10.1016/j.biopsych.2015.08.009
3. Angst, J., and Dobler-Mikola, A. (1984). Do the diagnostic criteria determine the sex ratio in depression? J. Affect. Disord. 7, 189-198. doi: 10.1016/0165-0327(84)90040-5
4. Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P. F., et al. (2011). NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475, 91-95. doi: 10.1038/nature10130
5. Bajbouj, M., Lisanby, S. H., Lang, U. E., Danker-Hopfe, H., Heuser, I., and Neu, P. (2006). Evidence for impaired cortical inhibition in patients with unipolar major depression. Biol. Psychiatry 59, 395-400. doi: 10.1016/j.biopsych.2005.07.036
6. Behlke, L. M., Foster, R. A., Liu, J., Benke, D., Benham, R. S., Nathanson, A. J., et al. (2016). A pharmacogenetic 'Restriction-of-Function' approach reveals evidence for anxiolytic-like actions mediated by alpha5-containing GABA receptors in mice. Neuropsychopharmacology 41, 2492-2501. doi: 10.1038/npp.2016.49
7. Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., et al. (2000). Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351-354. doi: 10.1016/S0006-3223(99)00230-9
8. A receptors regulate the intrinsic excitability of mouse hippocampal pyramidal neurons. J. Neurophysiol. 98, 2244-2254. doi: 10.1152/jn.00482.2007
9. Botta, P., Demmou, L., Kasugai, Y., Markovic, M., Xu, C., Fadok, J. P., et al. (2015). Regulating anxiety with extrasynaptic inhibition. Nat. Neurosci. 18, 1493-1500. doi: 10.1038/nn1215-1862a
10. Breslau, N., Schultz, L., and Peterson, E. (1995). Sex differences in depression: a role for preexisting anxiety. Psychiatry Res. 58, 1-12. doi: 10.1016/0165-1781(95)02765-O
11. Brickley, S. G., and Mody, I. (2012). Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73, 23-34. doi: 10.1016/j.neuron.2011.12.012
12. Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., et al. (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc. Natl. Acad. Sci. U.S.A. 102, 15653-15658. doi: 10.1073/pnas.0507901102
13. Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., et al. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373, 746-758. doi: 10.1016/S0140-6736(09)60046-5
14. A receptor. J. Neurosci. 22, 5572-5580.
15. de Sa-Calcada, D., Roque, S., Branco, C., Monteiro, S., Cerqueira-Rodrigues, B., Sousa, N., et al. (2015). Exploring female mice interstrain differences relevant for models of depression. Front. Behav. Neurosci. 9:335. doi: 10.3389/fnbeh.2015.00335
16. Earnheart, J. C., Schweizer, C., Crestani, F., Iwasato, T., Itohara, S., Mohler, H., et al. (2007). GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J. Neurosci. 27, 3845-3854. doi: 10.1523/JNEUROSCI.3609-06.2007
17. Edgar, N. M., Touma, C., Palme, R., and Sibille, E. (2011). Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1. Trans. Psychiatry 1:e42. doi: 10.1038/tp.2011.40
18. Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J., et al. (2013). Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 10:e1001547. doi: 10.1371/journal.pmed.1001547
19. Fischell, J., Van Dyke, A. M., Kvarta, M. D., LeGates, T. A., and Thompson, S. M. (2015). Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of Alpha5-Containing GABA receptors. Neuropsychopharmacology 40, 2499-2509. doi: 10.1038/npp.2015.112
20. Gilabert-Juan, J., Castillo-Gomez, E., Guirado, R., Molto, M. D., and Nacher, J. (2013). Chronic stress alters inhibitory networks in the medial prefrontal cortex of adult mice. Brain Struct. Funct. 218, 1591-1605. doi: 10.1007/s00429-012-0479-1
21. Guilloux, J. P., Douillard-Guilloux, G., Kota, R., Wang, X., Gardier, A. M., Martinowich, K., et al. (2012). Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol. Psychiatry 17, 1130-1142. doi: 10.1038/mp.2011.113
22. Guilloux, J. P., Seney, M., Edgar, N., and Sibille, E. (2011). Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: relevance to emotionality and sex. J. Neurosci. Methods 197, 21-31. doi: 10.1016/j.jneumeth.2011.01.019
23. Haberman, R. P., Colantuoni, C., Stocker, A. M., Schmidt, A. C., Pedersen, J. T., and Gallagher, M. (2011). Prominent hippocampal CA3 gene expression profile in neurocognitive aging. Neurobiol. Aging 32, 1678-1692. doi: 10.1016/j.neurobiolaging.2009.10.005
24. Herman, J. P., and Larson, B. R. (2001). Differential regulation of forebrain glutamic acid decarboxylase mRNA expression by aging and stress. Brain Res. 912, 60-66. doi: 10.1016/S0006-8993(01)02641-5
25. Isingrini, E., Belzung, C., Freslon, J. L., Machet, M. C., and Camus, V. (2012). Fluoxetine effect on aortic nitric oxide-dependent vasorelaxation in the unpredictable chronic mild stress model of depression in mice. Psychos. Med. 74, 63-72. doi: 10.1097/PSY.0b013e31823a43e0
26. Isingrini, E., Surget, A., Belzung, C., Freslon, J. L., Frisbee, J., O'Donnell, J., et al. (2011). Altered aortic vascular reactivity in the unpredictable chronic mild stress model of depression in mice: UCMS causes relaxation impairment to ACh. Physiol. Behav. 103, 540-546. doi: 10.1016/j.physbeh.2011.04.002
27. Kato, T. (2007). Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 61, 3-19. doi: 10.1111/j.1440-1819.2007.01604.x
28. Kessler, R. C. (2003). Epidemiology of women and depression. J. Affect. Disord. 74, 5-13. doi: 10.1016/S0165-0327(02)00426-3
29. Koh, M. T., Rosenzweig-Lipson, S., and Gallagher, M. (2013). Selective GABA(A) alpha5 positive allosteric modulators improve cognitive function in aged rats with memory impairment. Neuropharmacology 64, 145-152. doi: 10.1016/j.neuropharm.2012.06.023
30. Krystal, J. H., Sanacora, G., Blumberg, H., Anand, A., Charney, D. S., Marek, G., et al. (2002). Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol. Psychiatry 7(Suppl. 1), S71-S80. doi: 10.1038/sj.mp.4001021
31. Li, N., Lee, B., Liu, R. J., Banasr, M., Dwyer, J. M., Iwata, M., et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959-964. doi: 10.1126/science.1190287
32. Lin, L. C., and Sibille, E. (2015). Somatostatin, neuronal vulnerability and behavioral emotionality. Mol. Psychiatry 20, 377-387. doi: 10.1038/mp.2014.184
33. Luscher, B., Shen, Q., and Sahir, N. (2011). The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 16, 383-406. doi: 10.1038/mp.2010.120
34. Ma, X. C., Jiang, D., Jiang, W. H., Wang, F., Jia, M., Wu, J., et al. (2011). Social isolation-induced aggression potentiates anxiety and depressive-like behavior in male mice subjected to unpredictable chronic mild stress. PLoS ONE 6:e20955. doi: 10.1371/journal.pone.0020955
35. Maggi, A., and Perez, J. (1986). Estrogen-induced up-regulation of gamma-aminobutyric acid receptors in the CNS of rodents. J. Neurochem. 47, 1793-1797. doi: 10.1111/j.1471-4159.1986.tb13090.x
36. Maguire, J., and Mody, I. (2007). Neurosteroid synthesis-mediated regulation of GABA(A) receptors: relevance to the ovarian cycle and stress. J. Neurosci. 27, 2155-2162. doi: 10.1523/JNEUROSCI.4945-06.2007
37. Maguire, J. L., Stell, B. M., Rafizadeh, M., and Mody, I. (2005). Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat. Neurosci. 8, 797-804. doi: 10.1038/nn1469
38. Matsumoto, K., Puia, G., Dong, E., and Pinna, G. (2007). GABA(A) receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress 10, 3-12. doi: 10.1080/10253890701200997
39. Melchior, M., Caspi, A., Milne, B. J., Danese, A., Poulton, R., and Moffitt, T. E. (2007). Work stress precipitates depression and anxiety in young, working women and men. Psychol. Med. 37, 1119-1129. doi: 10.1017/S0033291707000414
40. Merali, Z., Du, L., Hrdina, P., Palkovits, M., Faludi, G., Poulter, M. O., et al. (2004). Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J. Neurosci. Neurosci. 24, 1478-1485. doi: 10.1523/JNEUROSCI.4734-03.2004
41. Moffitt, T. E., Harrington, H., Caspi, A., Kim-Cohen, J., Goldberg, D., Gregory, A. M., et al. (2007). Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch. Gen. Psychiatry 64, 651-660. doi: 10.1001/archpsyc.64.6.651
42. Navarro, J. F., Buron, E., and Martin-Lopez, M. (2002). Anxiogenic-like activity of L-655,708, a selective ligand for the benzodiazepine site of GABA(A) receptors which contain the alpha-5 subunit, in the elevated plus-maze test. Prog. Neuro-Psychopharmacol. 26, 1389-1392. doi: 10.1016/S0278-5846(02)00305-6
43. Northoff, G., and Sibille, E. (2014). Why are cortical GABA neurons relevant to internal focus in depression? A cross-level model linking cellular, biochemical and neural network findings. Mol. Psychiatry 19, 966-977. doi: 10.1038/mp.2014.68
44. A receptors: the approximated activation of receptor subtypes may explain behavioral effects. Brain Res. 1554, 36-48. doi: 10.1016/j.brainres.2014.01.036
45. Oquendo, M. A., Barrera, A., Ellis, S. P., Li, S., Burke, A. K., Grunebaum, M., et al. (2004). Instability of symptoms in recurrent major depression: a prospective study. Am. J. Psychiatry 161, 255-261. doi: 10.1176/appi.ajp.161.2.255
46. Otani, K., Ujike, H., Tanaka, Y., Morita, Y., Katsu, T., Nomura, A., et al. (2005). The GABA type A receptor alpha5 subunit gene is associated with bipolar I disorder. Neurosci. Lett. 381, 108-113. doi: 10.1016/j.neulet.2005.02.010
47. Overall, J. E., and Rhoades, H. M. (1982). Use of the hamilton rating scale for classification of depressive disorders. Compr. Psychiatry 23, 370-376. doi: 10.1016/0010-440X(82)90087-6
48. Pabba, M., Wong, A. Y., Ahlskog, N., Hristova, E., Biscaro, D., Nassrallah, W., et al. (2014). NMDA receptors are upregulated and trafficked to the plasma membrane after sigma-1 receptor activation in the rat hippocampus. J. Neurosci. 34, 11325-11338. doi: 10.1523/JNEUROSCI.0458-14.2014
49. Packer, A. M., McConnell, D. J., Fino, E., and Yuste, R. (2013). Axo-dendritic overlap and laminar projection can explain interneuron connectivity to pyramidal cells. Cereb. Cortex 23, 2790-2802. doi: 10.1093/cercor/bhs210
50. Piccinelli, M., and Wilkinson, G. (2000). Gender differences in depression. Critic. Rev. Br. J. Psychiatry J. Ment. Sci. 177, 486-492. doi: 10.1192/bjp.177.6.486
51. Quesseveur, G., Portal, B., Basile, J. A., Ezan, P., Mathou, A., Halley, H., et al. (2015). Attenuated levels of hippocampal connexin 43 and its phosphorylation correlate with antidepressant- and anxiolytic-like activities in mice. Front. Cell. Neurosci. 9:490. doi: 10.3389/fncel.2015.00490
52. Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., and Miguel-Hidalgo, J. J. (2007). GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology 32, 471-482. doi: 10.1038/sj.npp.1301234
53. Rush, A. J. (2010). Combining antidepressant medications: a good idea? Am. J. Psychiatry 167, 241-243. doi: 10.1176/appi.ajp.2009.09121768
54. Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y. T., Appel, M., Rothman, D. L., et al. (2004). Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. GenPsychiatry 61, 705-713. doi: 10.1001/archpsyc.61.7.705
55. Sanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A., et al. (1999). Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 56, 1043-1047. doi: 10.1001/archpsyc.56.11.1043
56. A receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists? Neuropsychopharmacology 33, 332-339. doi: 10.1038/sj.npp.1301403
57. A receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Prog. Neuro-psychopharmacol. Biol. Psychiatry 34, 376-386. doi: 10.1016/j.pnpbp.2010.01.004
58. Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., et al. (2011). Global quantification of mammalian gene expression control. Nature 473, 337-342. doi: 10.1038/nature10098
59. Seney, M. L., Chang, L. C., Oh, H., Wang, X., Tseng, G. C., Lewis, D. A., et al. (2013). The role of genetic sex in affect regulation and expression of GABA-Related genes across species. Front. Psychiatry 4:104. doi: 10.3389/fpsyt.2013.00104
60. Seney, M. L., Tripp, A., McCune, S., Lewis, D., and Sibille, E. (2014). Laminar and cellular analyses of reduced somatostatin gene expression in the subgenual anterior cingulate cortex in major depression. Neurobiol. Dis. 73C, 213-219.
61. Serra, M., Mostallino, M. C., Talani, G., Pisu, M. G., Carta, M., Mura, M. L., et al. (2006). Social isolation-induced increase in alpha and delta subunit gene expression is associated with a greater efficacy of ethanol on steroidogenesis and GABA receptor function. J. Neurochem. 98, 122-133. doi: 10.1111/j.1471-4159.2006.03850.x
62. Shen, Q., Lal, R., Luellen, B. A., Earnheart, J. C., Andrews, A. M., and Luscher, B. (2010). gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression. Biol. Psychiatry 68, 512-520. doi: 10.1016/j.biopsych.2010.04.024
63. Sibille, E., Morris, H. M., and Lewis, D. A. (2010). GABA-related Transcripts in the Dorsolateral Prefrontal Cortex in Mood Disorders. submitted.
64. Soumier, A., and Sibille, E. (2014). Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology 39, 2252-2262. doi: 10.1038/npp.2014.76
65. Surget, A., Wang, Y., Leman, S., Ibarguen-Vargas, Y., Edgar, N., Griebel, G., et al. (2009). Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 34, 1363-1380. doi: 10.1038/npp.2008.76
66. Tripp, A., Kota, R. S., Lewis, D. A., and Sibille, E. (2011). Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol. Dis. 42, 116-124. doi: 10.1016/j.nbd.2011.01.014
67. Tripp, A., Oh, H., Guilloux, J. P., Martinowich, K., Lewis, D. A., and Sibille, E. (2012). Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am. J. Psychiatry 169, 1194-1202. doi: 10.1176/appi.ajp.2012.12020248
68. Uusi-Oukari, M., and Korpi, E. R. (2010). Regulation of GABA(A) receptor subunit expression by pharmacological agents. Pharmacol. Rev. 62, 97-135. doi: 10.1124/pr.109.002063
69. Vinkers, C. H., and Olivier, B. (2012). Mechanisms underlying tolerance after long-term benzodiazepine use: a future for subtype-selective GABA(A) receptor modulators? Adv. Pharmacol. Sci. 2012:416864. doi: 10.1155/2012/416864
70. Wainwright, A., Sirinathsinghji, D. J., and Oliver, K. R. (2000). Expression of GABA(A) receptor alpha5 subunit-like immunoreactivity in human hippocampus. Brain Res. Mol. Brain Res. 80, 228-232. doi: 10.1016/S0169-328X(00)00133-9
71. Watson, I. P., Brune, M., and Bradley, A. J. (2016). The evolution of the molecular response to stress and its relevance to trauma and stressor-related disorders. Neurosci. Biobehav. Rev. 68, 134-147. doi: 10.1016/j.neubiorev.2016.05.010
72. Willner, P. (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110. doi: 10.1159/000087097
73. Zarate, C. A. Jr., Brutsche, N., Laje, G., Luckenbaugh, D. A., Venkata, S. L., Ramamoorthy, A., et al. (2012a). Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol. Psychiatry 72, 331-338. doi: 10.1016/j.biopsych.2012.03.004
74. Zarate, C. A. Jr., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., et al. (2012b). Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol. Psychiatry 71, 939-946. doi: 10.1016/j.biopsych.2011.12.010
75. A receptor function impairs memory after anesthesia. J. Clin. Invest. 124, 5437-5441. doi: 10.1172/JCI76669